Safety evaluation of certain food additives - ipcs inchem

444 ALKOXY-SUBSTITUTED ALLYLBENZENES
Gardner, I., Bergin, P., Stening, P., Kenna, J.G. & Caldwell, J. (1995) Protein adducts derived
from methyleugenol. In: Meeting report of the 4th International ISSX Meeting, Vol. 8.
Washington, DC, USA, International Society for the Study of Xenobiotics, p. 208.
Gardner, I., Bergin, P., Stening, P., Kenna, J.G. & Caldwell, J. (1996) Immunochemical
detection of covalently modified protein adducts in livers of rats treated with methyleugenol.
Crit. Rev. Toxicol., 9(4), 713–721.
Gardner, I., Wakazono, H., Bergin, P., deWaziers, I., Beaune, P., Kenna, J.G. & Caldwell, J.
(1997a) Cytochrome P450 mediated bioactivation of methyleugenol to 1hydroxymethyleugenol
in Fischer 344 rat and human liver microsomes. Carcinogenesis,
18(9), 1775–1783.
Gardner, I.B., Blench, I., Morris, H.R., Caldwell, J. & Kenna, J.G. (1997b) Covalent
modification of the laminin receptor precursor protein by reactive metabolites of
methyleugenol. In: Meeting report of the 6th International ISSX Meeting, Vol. 11.
Washington, DC, USA, International Society for the Study of Xenobiotics, p. 244.
Garner, R.C. & Campbell, J. (1985) Tests for the induction of mutations to ouabain or 6thioguanine
resistance in mouse lymphoma L5178Y cells. In: Ashby, J., De Serres, F.J.,
Draper, M., Ishidate, M., Jr, Margolin, B.M., Matter, B.E. & Shelby, M.D., eds. Evaluation
of short-term tests for carcinogens. Report of the International Programme on Chemical
Safety’s Collaborative Study on In Vitro Assays. Amsterdam, Netherlands, Elsevier,
pp. 525–529 (Progress in Mutation Research, Volume 5).
Garner, R.C., Welch, A. & Pickering, C. (1981) Mutagenic activity of 42 coded compounds in
the Salmonella/microsome assay. In: De Serres, F.J. & Ashby, J., eds. Evaluation of shortterm
tests for carcinogens. Report of the international collaborative program. New York,
NY, USA, Elsevier, pp. 280–284 (Progress in Mutation Research, Volume 1).
Gatehouse, D. (1981) Mutagenic activity of 42 coded compounds in the “microtiter” fluctuation
test. In: De Serres, F.J. & Ashby, J., eds. Evaluation of short-term tests for carcinogens.
Report of the international collaborative program. New York, NY, USA, Elsevier,
pp. 376–386 (Progress in Mutation Research, Volume 1).
Gavin, C.L., Williams, M.C. & Hallagan, J.B. (2007) 2005 FEMA poundage and technical
effects update survey. Washington, DC, USA, Flavor and Extract Manufacturers
Association.
Glauert, H.P., Kennan, W.S., Sattler, G.L. & Pitot, H.C. (1985) Assays to measure the induction
of unscheduled DNA synthesis in cultured hepatocytes. In: Ashby, J., De Serres, F.J.,
Draper, M., Ishidate, M., Jr, Margolin, B.M., Matter, B.E. & Shelby, M.D., eds. Evaluation
of short-term tests for carcinogens. Report of the International Programme on Chemical
Safety’s Collaborative Study on In Vitro Assays. Amsterdam, Netherlands, Elsevier,
pp. 371–373 (Progress in Mutation Research, Volume 5).
Gocke, E., King, M.-T., Eckhardt, K. & Wild, D. (1981) Mutagenicity of cosmetics ingredients
licensed by the European Communities. Mutat. Res., 90, 91–109.
Graves, S.W. & Runyon, S. (1995) Determination of methyleugenol in rodent plasma by highperformance
liquid chromatography. J. Chromatogr. B Biomed. Appl., 663(2), 255–262.
Green, M.H.L. (1981) A differential killing test using an improved repair-deficient strain of
Escherichia coli. In: De Serres, F.J. & Ashby, J., eds. Evaluation of short-term tests for
carcinogens. Report of the international collaborative program. New York, NY, USA,
Elsevier, pp. 183–194 (Progress in Mutation Research, Volume 1).
Green, N.R. (1975) Screening of safrole, eugenol, their ninhydrin positive metabolites and
selected secondary amines for potential mutagenicity. Diss. Abstr. Int., 35(8), 3964.
Green, N.R. & Savage, J.R. (1978) Screening of safrole, eugenol, their ninhydrin positive
metabolites and selected secondary amines for potential mutagenicity. Mutat. Res., 57,
115–121.
Gulati, D.K., Sabharwal, P.S. & Shelby, M.D. (1985) Tests for the induction of chromosomal
aberrations and sister chromatid exchanges in cultured Chinese hamster ovary (CHO)